Epstein Barr virus associated smooth muscle tumors in the central nervous system: a case report and systematic review of the literature V. M. WillekeM. P. AndersonE. M. Kasper Topic Review 05 March 2020 Pages: 247 - 260
Super selective intra-arterial cerebral infusion of modern chemotherapeutics after blood–brain barrier disruption: where are we now, and where we are going Randy S. D’AmicoDeepak KhatriJohn A. Boockvar Topic Review 19 February 2020 Pages: 261 - 278
Correction to: Super selective intra‑arterial cerebral infusion of modern chemotherapeutics after blood–brain barrier disruption: where are we now, and where we are going Randy S. D’AmicoDeepak KhatriJohn A. Boockvar Correction 13 March 2020 Pages: 279 - 279
T-Cell based therapies for overcoming neuroanatomical and immunosuppressive challenges within the glioma microenvironment Darwin KwokHideho Okada Topic Review 17 March 2020 Pages: 281 - 295
Trends in glioblastoma: outcomes over time and type of intervention: a systematic evidence based analysis Lina Marenco-HillembrandOlindi WijesekeraKaisorn L. Chaichana Topic Review 09 March 2020 Pages: 297 - 307
A genome-wide association study on medulloblastoma Anna M. DahlinCarl WibomBeatrice Melin Laboratory Investigation Open access 13 February 2020 Pages: 309 - 315
The contribution of ketone bodies to glycolytic inhibition for the treatment of adult and pediatric glioblastoma Frederic A. VallejoSumedh S. ShahRegina M. Graham Laboratory Investigation 24 February 2020 Pages: 317 - 326
Reciprocal control of ADAM17/EGFR/Akt signaling and miR-145 drives GBM invasiveness Yuduo GuoXin HeHongwei Zhang Laboratory Investigation 13 March 2020 Pages: 327 - 337
Primary central nervous system lymphoma involving the hypothalamic–pituitary axis: a case series and pooled analysis Dong-Won ShinJeong Hoon KimSeok Ho Hong Clinical Study 27 March 2020 Pages: 339 - 349
LINAC-based stereotactic radiosurgery versus hypofractionated stereotactic radiotherapy delivered in 3 or 5 fractions for vestibular schwannomas: comparative assessment from a single institution Linn Söderlund DiazAndreas Hallqvist Clinical Study 08 February 2020 Pages: 351 - 359
Disparities in glioblastoma survival by case volume: a nationwide observational study Rahul RajKarri SeppäMiikka Korja Clinical Study Open access 14 February 2020 Pages: 361 - 370
Fertility preservation outcomes in women with gliomas: a retrospective case–control study Taylor NordanAnn M. ThomasPietro Bortoletto Clinical Study 14 February 2020 Pages: 371 - 376
Surgical treatment and survival outcome of patients with adult thalamic glioma: a single institution experience of 8 years Xiaodong NiuTianwei WangQing Mao Clinical Study 10 March 2020 Pages: 377 - 386
Clinical outcomes following proton therapy for adult craniopharyngioma: a single-institution cohort study Michael S. RutenbergRonny L. RotondoWilliam M. Mendenhall Clinical Study 21 February 2020 Pages: 387 - 395
The prevalence of altered body image in patients with primary brain tumors: an understudied population Lindsay RoweElizabeth VeraTerri Armstrong Clinical Study Open access 24 February 2020 Pages: 397 - 404
Extent of re-excision, sequence/timing of salvage re-irradiation, and disease-free interval impact upon clinical outcomes in recurrent/progressive ependymoma Tejpal GuptaMadan MaitreJayant GodaSastri Clinical Study 18 February 2020 Pages: 405 - 415
Variations in screening and management practices for subsequent asymptomatic meningiomas in childhood, adolescent and young adult cancer survivors Lisanne C. VerbruggenMelissa M. HudsonRenée L. Mulder Clinical Study 22 February 2020 Pages: 417 - 425
Clinical presentation of young people (10–24 years old) with brain tumors: results from the international MOBI-Kids study Angela Zumel-MarneMichael KundiElisabeth Cardis Clinical Study Open access 03 March 2020 Pages: 427 - 440
Long-term outcomes of multimodality management for parasagittal meningiomas Lingyang HuaDaijun WangYe Gong Clinical Study 22 February 2020 Pages: 441 - 450
Improvement in resiliency factors among adolescents with neurofibromatosis who participate in a virtual mind–body group program Ethan G. LesterEric A. MacklinAna-Maria Vranceanu Clinical Study 20 February 2020 Pages: 451 - 457
Selumetinib for plexiform neurofibromas in neurofibromatosis type 1: a single-institution experience Vera Espírito SantoJoão PassosSofia Nunes Clinical Study 27 February 2020 Pages: 459 - 463
Outcomes after stereotactic radiosurgery for CNS lymphoma Joshua D. PalmerDeepak BhamidipatiWenyin Shi Clinical Study 27 February 2020 Pages: 465 - 476
Patterns of relapse after successful completion of initial therapy in primary central nervous system lymphoma: a case series Mallika P. PatelJohn P. KirkpatrickKatherine B. Peters Clinical Study 05 March 2020 Pages: 477 - 483
Healthcare utilization and productivity loss in glioma patients and family caregivers: the impact of treatable psychological symptoms Florien W. BoeleDavid MeadsMartin Klein Clinical Study Open access 14 March 2020 Pages: 485 - 494
Racial and socioeconomic correlates of treatment and survival among patients with meningioma: a population-based study Hriday P. BhambhvaniAdrian J. RodriguesMelanie Hayden Gephart Clinical Study 19 March 2020 Pages: 495 - 501
